Legal & General Group’s Caribou Biosciences CRBU Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | – | Sell |
-6,941
| Closed | -$6.34K | – | 3443 |
|
2025
Q1 | $6.34K | Hold |
6,941
| – | – | ﹤0.01% | 3246 |
|
2024
Q4 | $11K | Hold |
6,941
| – | – | ﹤0.01% | 3235 |
|
2024
Q3 | $13.6K | Hold |
6,941
| – | – | ﹤0.01% | 3194 |
|
2024
Q2 | $11.4K | Hold |
6,941
| – | – | ﹤0.01% | 3268 |
|
2024
Q1 | $35.7K | Hold |
6,941
| – | – | ﹤0.01% | 2823 |
|
2023
Q4 | $39.8K | Buy |
6,941
+747
| +12% | +$4.28K | ﹤0.01% | 2838 |
|
2023
Q3 | $29.6K | Buy |
6,194
+684
| +12% | +$3.27K | ﹤0.01% | 2924 |
|
2023
Q2 | $23.4K | Sell |
5,510
-2,249
| -29% | -$9.56K | ﹤0.01% | 3049 |
|
2023
Q1 | $41.2K | Sell |
7,759
-10,437
| -57% | -$55.4K | ﹤0.01% | 2911 |
|
2022
Q4 | $114K | Buy |
18,196
+429
| +2% | +$2.69K | ﹤0.01% | 2790 |
|
2022
Q3 | $188K | Buy |
17,767
+1,294
| +8% | +$13.7K | ﹤0.01% | 2655 |
|
2022
Q2 | $89K | Buy |
16,473
+5,240
| +47% | +$28.3K | ﹤0.01% | 2885 |
|
2022
Q1 | $103K | Buy |
11,233
+3,080
| +38% | +$28.2K | ﹤0.01% | 2856 |
|
2021
Q4 | $123K | Buy |
8,153
+6,355
| +353% | +$95.9K | ﹤0.01% | 2866 |
|
2021
Q3 | $43K | Buy |
+1,798
| New | +$43K | ﹤0.01% | 3017 |
|